Ergoteles’s Curis CRIS Stock Holding History

Ergoteles’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-187	Closed	-$41.2K	–	1347
2022 Q4	$41.2K	Sell	187 -124	-40%	-$36.4K	﹤0.01%	1313
2022 Q3	$87K	Sell	311 -1,184	-79%	-$477K	﹤0.01%	1398
2022 Q2	$589K	Buy	+1,495	New	+$624K	0.02%	768
2021 Q2	–	Sell	-29	Closed	-$131K	–	1519
2021 Q1	$131K	Buy	+29	New	+$121K	﹤0.01%	717

Other funds holding CRIS

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's CRIS Position: Q1 2023 in Review

Ergoteles sold out of Curis (CRIS) in Q1 2023, closing a stake of 187 shares — an estimated $41.2K sold.

Ergoteles first reported a position in CRIS in Q1 2021 and held it in 4 quarters. The position peaked at $589K in Q2 2022. 57 funds tracked by Wall St. Rank hold CRIS as of Q1 2023.

Ergoteles reported no remaining Curis position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 187 Curis shares in Q1 2023, an estimated $41.2K.
Ergoteles first reported a position in Curis in Q1 2021 and held it in 4 quarters.
Ergoteles's Curis position peaked at $589K in Q2 2022.
57 funds tracked by Wall St. Rank held Curis as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.